March 15 (Reuters) - M Pharmaceutical Inc MQ.CD
* Mathew Lehman has resigned from board of directors and
from his position as President and CEO
* Company is undertaking a search for a new CEO
* Previously announced letter of intent to acquire
reformulated Orlistat from Chelatexx, LLC allowed to lapse by
parties
Source text for Eikon: ID:nCCN5J8YPP
Further company coverage: MQ.CD